RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: RAD001|DRUG: Dexamethasone
Sponsor: M.D. Anderson Cancer Center
Collaborators: Novartis Pharmaceuticals